{"organizations": [], "uuid": "ebb050f1fb975beb9a71221c5ce61f31d2b6290d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/26/globe-newswire-flexion-therapeutics-to-report-fourth-quarter-and-full-year-2017-financial-results-on-march-8-2018.html", "country": "US", "domain_rank": 767, "title": "Flexion Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 8, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-27T00:30:00.000+02:00", "replies_count": 0, "uuid": "ebb050f1fb975beb9a71221c5ce61f31d2b6290d"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/26/globe-newswire-flexion-therapeutics-to-report-fourth-quarter-and-full-year-2017-financial-results-on-march-8-2018.html", "ord_in_thread": 0, "title": "Flexion Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 8, 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "mass.", "sentiment": "none"}, {"name": "burlington", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "flexion therapeutics, inc.", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "BURLINGTON, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its fourth quarter and full year 2017 financial results after the close of the U.S. financial markets on Thursday, March 8, 2018. Flexionâ€™s management will host a conference call at 4:30 p.m. ET to discuss the results and provide an update on business operations.\nThe dial-in number for the conference call is 1-855-770-0022 for domestic participants and 1-908-982-4677 for international participants, with Conference ID #7699053. A live webcast of the conference call can also be accessed through the \" Investors \" tab on the Flexion Therapeutics website. A webcast replay will be available online after the call.\nAbout Flexion Therapeutics\nFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Flexion was named one of The Boston Business Journal's 2017 Best Places to Work and one of the Top Places to Work in Massachusetts by The Boston Globe .\nContact:\nScott Young\nVice President, Corporate Communications and Investor Relations\nFlexion Therapeutics, Inc.\nT: 781-305-7194\nsyoung@flexiontherapeutics.com\nSource:Flexion Therapeutics, Inc.", "external_links": ["https://www.globenewswire.com/Tracker?data=bjp66s5nKJvYSjM2wU5-d9YPf_MLORVtjSKexVcqPA2NKJYCXsB2KMTucMmnPuKY8iYknRm3lhZtrscoxgEGB49Bv7jksyp3gPBJnjj3lTc=", "https://www.globenewswire.com/Tracker?data=Sfh0K3CmcoLNjKlV8i8k25LkJZManYjNPbM88GKzjCeduA_BJ56joBrg8ewIdb8QevAbr-pDkFqemH9zS2Ommvri_bxOERE29UdJCMvYAt3SJi_gXXgQLlgC7o-JZ-7z", "https://www.globenewswire.com/NewsRoom/AttachmentNg/8bf07d58-f008-4e24-95d9-5383392d4cbb"], "published": "2018-02-27T00:30:00.000+02:00", "crawled": "2018-02-27T00:29:19.012+02:00", "highlightTitle": ""}